Identifying counterfeit medicines using near infrared spectroscopy

Journal of Near Infrared Spectroscopy

Volumn 18, Issue 1, 2010, Pages 1-15

  Moffat, Anthony C ^a   Assi, Sulaf ^a   Watt, Robert A ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Active pharmaceutical ingredient; Assay; Counterfeit medicines; Identification; Near infrared spectroscopy; Quantification; Sub standard medicines; Suspect medicines

Indexed keywords

EID: 77951192030     PISSN: 09670335     EISSN: None     Source Type: Journal    
DOI: 10.1255/jnirs.856     Document Type: Review

References (90)

1. WHO, "International Medical Products AntiCounterfeiting Task Force (IMPACT)", http://www.who. int/impact/impact-q-a/en/index.html (2008).
2. H. Wright and J. Nicholson. "Combating counterfeit medicines", Pharm. J. 282,193 (2009).
3. G. Phillips, "Anticounterfeiting measures", Pharm. J. 271, 465 (2003).
4. A.K. Deisingh, "Pharmaceutical counterfeiting", Analyst 130, 271 (2005). doi: 10.1039/b407759h
5. S. Singh, B. Prasad, A.A. Savaliya, R.P Shah, V.M. Gohil and A. Kuhr. "Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs", Trends Anal. Chem. 28,13 (2009). doi: 10.1016/j.trac.2008.09.004
6. W.L. Yoon, "Near-infrared spectroscopy: A novel tool to detect pharmaceutical counterfeits", Am. Pharm. Rev. 8, 115(2005).
7. M. Ulmschneiderand E. Pénigault, "Non-invasive confirmation of the identity of tablets by near-infrared spectroscopy". Analusis 28, 336 (2000). doi: 10.1051/analusis:2000124
8. S.H.F. Scafi and C. Pasquini, "Identification of counterfeit drugs using near-infrared spectroscopy", Analyst 126, 2218 (2001). doi: 10.1039/b106744n
9. O.Y. Rodionova, L.P. Houmoller. A.L. Pomerantsev, P. Geladi, J. Burger. V.L. Dorofeyev and A.P. Arzamastsev, "NIR spectrometry for counterfeit detection a feasibility study", Anal. Chim. Acta 549,151 (2005). doi: 10.1016/j. aca.2005.06.018
10. B.A. Olsen. M.W. Borer, F.M. Perry and R.A. Forbes. "Screening for counterfeit drugs using near-infrared spectroscopy", Pharm. Tech. North America 26, 62 (2002).
11. M.J. Vredenbregt, D. Mooibroek, D. de Kaste and R. Hoogerbrugge, "Screening Viagra tablets with near infrared spectroscopy", in Near Infrared Spectroscopy: Proceedings of the 11th International Conference, Ed by A.M.C. Davies and A. Garrido-Varo. NIR Publications, Chichester. UK, p. 1073(2004).
12. M.J. Vredenbregt, L. Blok-Tip, R. Hoogerbrugge, D.M. Barends and D. de Kaste, "Screening suspected counterfeit Viagra and imitations of Viagra with near-infrared spectroscopy". J. Pharm. Biomed. Anal. 40, 840 (2006). doi: 10.1016/j.jpba.2005.07.048
13. M.J. Vredenbregt, D. Mooibroek and R. Hoogerbrugge, "Your Viagra's genuine, imitation or counterfeit?", in Handbook of Near-infrared Analysis, Ed by D.A. Burns and E.W. Ciurczak. CRC, Boca Raton. USA, p. 631 (2008).
14. L. Block-Tip, H. Vogelpoel, M.J. Vredenbregt, D.M. Barends and D. de Kaste. Counterfeits and Imitations of Viagra and Cialis Tablets: Trends and Risks to Public Health. Rijksinstituut voorVolksgezondheid en Milieu, Bilthoven, The Netherlands (2005).
15. M. Shin, R.D. Jee, K. Chae and A.C. Moffat, "Identification of counterfeit Cialis, Levitra and Viagra tablets by near-infrared spectroscopy", J. Pharm. Pharmacol. 57 Supplement, S-11 (2005).
16. P. de Pinder. M.J. Vredenbregt. T. Visser and D.E. Kaste, "Detection of Lipitor counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometrics", J. Pharm. Biomed. Anal. 47, 688 (2008). doi: 10.1016/j.jpba.2008.02.016
17. S.H. Tabasi, J. Polli and S. Hoag, "Application of near infrared spectroscopy to differentiate counterfeit and authentic drug products", AAPS J, 9 Supplement, Abstract 2894 (2007).
18. W.L. Yoon. R.D. Jee, G. Lee, A. Charvill and A.C. Moffat, "A non-destructive method to detect counterfeit medicines using near-infrared spectroscopy", AAPS Pharm. Sci. 3 Supplement, Abstract 428 (2001).
19. W.L. Yoon. R.D. Jee, A. Charvill, G. Lee and A.C. Moffat, "Application of near-infrared spectroscopy to the determination of the sites of manufacture of proprietary products", J. Pharm. Biomed. Anal. 34, 933 (2004). doi: 10.1016/j.jpba.2003.11.014
20. Y. Roggo. C. Roeseler and M. Ulmschneider, "Near infrared spectroscopy for qualitative comparison of pharmaceutical batches". J. Pharm. Biomed. Anal. 36, 777 (2004). doi: 10.1016/j.jpba.2004.08.009
21. Y. Roggo, C. Roeseler, P. Chalus and A. Fischer, "Comparison of pharmaceutical batches by near infrared spectroscopy", NIR news 16, 12 (2005).
22. A. O'Neil. R. Jee, G. Lee. A. Charvill and A. Moffat. "Transfer of qualitative NIR methods for tablet authentication and counterfeit detection", AAPS J. 9, Abstract W5092 (2007).
23. P.R. Khan. R.D. Jee, R.A.Watt and A.C. Moffat, "The identification of active drugs in tablets using near infrared spectroscopy", Pharm. Sci. 3, 447 (1997).
24. Y.C. Feng and C.Q. Hu, "Construction of universal quantitative models for determination of roxithromycin and erythromycin ethylsuccinate in tablets from different manufacturers using near infrared reflectance spectroscopy". J. Pharm. Biomed. Anal. 41, 373 (2006). doi: 10.1016/j.jpba.2005.11.027
25. Y.C. Feng and C.Q. Hu, "Use of near infrared spectroscopy in the screening of counterfeit and sub-standard drugs: Quantitative applications", in Near Infrared Spectroscopy: Proceedings of the 12th International Conference, Ed by G.R. Burling-Claridge, S.E. Holroyd and R.M.W. Sumner. New Zealand Infrared Spectroscopy Society. Hamilton, New Zealand, p. 726 (2007).
26. X.M. Chong, C.Q. Hu, Y.C. Feng and H.H. Pang, "Construction of a universal model for non-invasive identification of cephalosporins for injection using near-infrared diffuse reflectance spectroscopy", Vib. Spectrosc. 49,196 (2009). doi: 10.1016/j.vibspec.2008.07.010
27. X.J. Cui, Z.Y. Zhang, P.D. Harrington and Y.L. Yen, "Quality control of the powder pharmaceutical samples of metronidazole based on near infrared reflectance spectra with temperature-constrained cascade correlation neural networks", Chinese J. Chinese Universities 25, 1251 (2004).
28. X. Cui, Z. Zhang, Y. Ren, S. Liu and P.D. Harrington, "Quality control of the powder pharmaceutical samples of sulfaguanidine by using NIR reflectance spectrometry and temperature-constrained cascade correlation networks". Talanta 64, 943 (2004). doi: 10.1016/j. talanta.2004.04.009
29. International Conference on Harmonisation, "Validation of analytical procedures: text and methodology Q2 (R1)" (2005) http://www.ich.org/LOB/ media/MEDIA417.pdf
30. A.C. Moffat, A.D. Trafford. R.D. Jee and P.Graham. "Meeting of the International Conference on Harmonisation's Guidelines on Validation of Analytical Procedures: quantification as exemplified by a nearinfrared reflectance assay of paracetamol in intact tablets", Analyst 125,1341 (2000). doi: 10.1039/b002672g
31. H. Mark, G.E. Ritchie, R.W. Roller, E. Ciurczak. C. Tso and S. MacDonald, "Validation of a near-infrared transmission spectroscopic procedure, part A: validation protocols", J. Pharm. Biomed. Anal. 28, 251 (2002). doi: 10.1016/ S0731-7085(01)00567-572
32. G.E. Ritchie, R.W. Roller, E.W. Ciurczak, H. Mark. C. Tso and S.A. MacDonald, "Validation of a near-infrared transmission spectroscopic procedure, part B: application to alternate content uniformity and release assay methods for pharmaceutical solid dosage forms". J. Pharm. Biomed. Anal. 29,159 (2002). doi: 10.1016/S07317085(02)00010-9
33. European Agency for the Evaluation of Medicinal Products, "Note for guidance on the use of neat infrared spectroscopy by the pharmaceutical industry and the data requirements for new submissions and variations", EMEA/CVMP/961/01 (2003). http://www.emea.europa. eu/pdfs/human/qwp/330901en.pdf
34. M. Blanco. J. Coello. H. Iturriaga, S. Maspoch, C. de la Pezuela and E. Russo, "Control analysis of a pharmaceutical preparation by near-infrared reflectance spectroscopy, a comparative study of a spinning module and fibre optic probe", Anal. Chim. Acta 298,183 (1994). doi: 10.1016/0003-2670(94) 00275-4
35. A. Eustaquio, P. Graham, R.D. Jee, A.C. Moffat and A. Trafford, "Quantification of paracetamol in intact tablets using near-infrared transmittance spectroscopy". Analyst 123, 2303 (1998). doi: 10.1039/a804528c
36. A. Eustaquio, M. Blanco, R.D. Jee and A.C. Moffat. "Determination of paracetamol in intact tablets by use of near infrared transmittance spectroscopy", Anal. Chim. Acta. 383, 283 (1999). doi: 10.1016/ S00032670(98)00815-0
37. A.D. Trafford, R.D. Jee, A.C. Moffat and P. Graham. "A rapid quantitative assay of intact paracetamol tablets by reflectance near-infrared spectroscopy". Analyst 124, 163(1999). doi: 10.1039/a806629i
38. M.R. Smith, R.D. Jee and A.C. Moffat, "The transfer between instruments of a reflectance near-infrared assay for paracetamol in intact tablets", Analyst 127, 1682 (2002). doi: 10.1039/b209269g
39. K. Molt, F. Zeyen and E. Podpetschnig-Fopp. "Quantitative near infrared spectrometry used for the determination of the drug content of tolbutamide tablets". Pharm. Ind. 58, 847 (1996).
40. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and D. Serrano, "Near-infrared analytical control of pharmaceuticals. A single calibration model from mixed phase to coated tablets", Analyst 123, 2307 (1998). doi: 10.1039/ a805946b
41. M. Blanco, A. Eustaquio, J.M. González and D. Serrano, "Identification and quantitation assays for intact tablets of two related pharmaceutical preparations by reflectance near-infrared spectroscopy: validation of the procedure". J. Pharm. Biomed. Anal. 22, 139 (2000). doi: 10.1016/ S0731-7085(99)00274-275
42. M. Blanco, J. Coello, A. Eustaquio, H. Iturriaga and S. Maspoch, "Development and validation of a method for the analysis of a pharmaceutical preparation by nearinfrared diffuse reflectance spectroscopy", J. Pharm. Sci. 88, 551 (1999). doi: 10.1021/js980338f
43. M. Blanco, J. Coella, A. Eustaquio, H. Iturriaga and S. Maspoch, "Analytical control of pharmaceutical production steps by near infrared reflectance spectroscopy", Anal. Chim. Acta 392, 237 (1999). doi: 10.1016/S00032670(99)00255-X
44. E. Dreassi. G. Ceramelli, L. Savini and P. Corti, "Application of near-infrared reflectance analysis to the integrated control of antibiotic tablet production", Analyst 120, 319 (1995). doi: 10.1039/an9952000319
45. M. Blanco, J. Coello, A. Eustaquio, H. Iturriaga and S. Maspoch, "Development and validation of methods for the determination of miokamycin in various pharmaceutical preparations by use of near infrared reflectance spectroscopy". Analyst 124, 1089 (1999). doi: 10.1039/ a901774g
46. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and C. de la Pezuela, "Strategies for constructing the calibration set in the determination of active principles in pharmaceuticals by near infrared diffuse reflectance spectrometry", Analyst 122, 761 (1997). doi: 10.1039/a700630f
47. M. Laasonen, T. Harmia-Pulkkinen. C. Simard, M. Räsänen, and H. Vuorela, "Development and valifdation of a near-infrared method for the quantitation of caffeine in intact single tablets", Anal. Chem. 75, 754 (2003). doi: 10.1021/ac026262w
48. E. Dreassi. G. Ceramelli, P. Corti, P.L. Perruccio and S. Leonardi. "Application of near-infrared reflectance spectrometry to the analytical control of pharmaceuticals: ranitidine hydrochloride tablet production", Analyst 121, 219 (1996). doi: 10.1039/an9962100219
49. P. Corti, E. Dreassi, G. Corbini, S. Lonardi, R. Viviani, L. Mosconi and M. Bernuzzi, "Application of near infrared reflectance to the analytical control of pharmaceuticals assay of ranitidine chlorohydrate and water content in tablets", Pharm. Acta Helv. 65, 28 (1990).
50. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and C. de la Pezuela. "Quantitation of the active compound and major excipients in a pharmaceutical formulation by near infrared diffuse reflectance spectroscopy with fibre optical probe", Anal. Chim. Acta 333, 147 (1996). doi: 10.1016/0003-2670(96)00250-4
51. D. Jouan-Rimbaud, B. Walczak, D.L. Massart. I.R. Last and K.A. Prebble, "Comparison of multivariate methods based on latent vectors and methods based on wavelength selection for the analysis of near-infrared spectroscopic data", Anal. Chim. Acta 304, 285 (1995). doi: 10.1016/0003-2670(94)00590-1
52. M.R. Smith, R.D. Jee. A.C. Moffat, D.R. Rees and N.W. Broad, "A procedure for calibration transfer between near-infrared instruments-a worked example using a transmittance single tablet assay for piroxicam in intact tablets", Analyst 129, 806 (2004). doi: 10.1039/ b401267d
53. I. Jedvert, M. Josefson and F. Langkilde, "Quantification of an active substance in a tablet by NIR and Raman spectroscopy", J. Near Infrared Specrosc. 6, 279 (1998). doi: 10.1255/jnirs.148
54. W. Fountatin, K. Dumstorf. A.E. Lowell, R.A. Lodder and R.J. Mumper, "Near-infrared spectroscopy for the determination of testosterone in thin-film composites", J. Pharm. Biomed. Anal. 33, 181 (2003). doi: 10.1016/S07317085(03)00345-5
55. M. Blanco, J. Coello, H. Iturriaga, S. Maspoch and C. de la Pezuela, "Determination of ascorbic acid in pharmaceutical preparations by near infrared reflectance spectroscopy", Talanta 40, 1671 (1993). doi: 10.1016/00399140(93)80083-4
56. J. Gottfries, H. Depui, M. Fransson. M. Jongeneelen, M. Josefson, F.W. Langkilde and D.T. Witte, "Vibrational spectrometry for the assessment of active substance in metoprolol tablets: a comparison between transmission and diffuse near-infrared spectrometry", J. Pharm. Biomed. Anal. 14, 1495 (1996). doi: 10.1016/07317085(96)01800-6
57. M.-W. Scheiwe, D. Schilling and P. Aebi. "NIR spectroscopy analysis of intact pharmaceutical diclofenac coated tablets in transmission", Pharm. Ind. 61, 179-183 (1999).
58. N.W. Broad, R.D. Jee, A.C. Moffat and M.R. Smith, "Application of transmission near-infrared spectroscopy to uniformity of content testing of intact steroid tablets", Analyst 126, 2207 (2001). doi: 10.1039/b106741a
59. P. Corti, G. Ceramelli, E. Dreassi and S. Mattii, "Near infrared transmittance analysis for the assay of solid pharmaceutical dosage forms". Analyst 124, 755 (1999). doi: 10.1039/a809800j
60. P. Merckle and K.-A. Kovar, "Assay of effervescent tablets by near-infrared spectroscopy in transmittance and reflectance mode: acetylsalicylic acid in mono and combined formulations". J. Pharm. Biomed. Anal. 17, 365 (1998). doi: 10.1016/S0731-7085(97)00194-5
61. M. Dyrby, S.B. Engelsen, L. Norgard, M. Bruhn and L. Lundsberg-Nielsen. "Chemometric quantitation of the active substance (containing C=N) in a pharmaceutical tablet using near-infrared (NIR) transmittance and NIR FT-Raman spectra", Appl. Spectrosc. 56, 579 (2002). doi: 10.1366/0003702021955358
62. A.C. Moffat. M.R. Smith. R.D. Jee and N.W. Broad, "Calibration transfer in near infrared spectroscopic process analytical technology", in Near Infrared Spectroscopy: Proceedings of the 12th International Conference, Ed by G.R. Burling-Claridge, S.E. Holroyd and R.M.W. Sumner. New Zealand Near Infrared Spectroscopy Sopciety, Hamilton, New Zealand, p. 734(2007).
63. M. Blanco and M. Alcala. "Simultaneous quantitation of five active principles in a pharmaceutical preparation: development and validation of a near infrared spectroscopic method", Eur. J. Pharm. Sci. 27, 280 (2006). doi: 10.1016/j.ejps.2005.10.008
64. S.M. Han and P.G. Faulkner, "Determination of SB-216469-S during tablet production using nearinfrared spectroscopy", J. Pharm. Biomed. Anal. 14, 1681 (1996). doi: 10.1016/0731-7085(96)01814-6
65. P. Chalus, Y. Roggo, S. Walter and M. Ulmschneider, "Near-infrared determination of active substance content in intact low-dosage tablets", Talanta 66,1294 (2005). doi: 10.1016/j.talanta.2005.01.051
66. Y. Chen, S.S. Thosar, R.A. Forbess, M.S. Kemper. R.L. Rubinovitz and A.J. Shukla, "Prediction of drug content and hardness of intact tablets using artificial neural networks and near-infrared spectroscopy", Drug Dev. Ind. Pharm. 27, 623 (2001). doi: 10.1081/DDC-100107318
67. S.S. Thosar, R.A. Forbess, N.K. Ebebe. Y. Chen. R.L. Rubinovitz, M.S. Kemper, G.E. Reier. T.A. Wheatley and A.J. Shukla, "A comparison of reflectance and transmittance techniques in determining drug content in intact tablets", J. Pharm. Dev. Technol. 6,19 (2001). doi: 10.1081/ PDT-100000010
68. M. Alcala, J. León, J. Ropero, M. Blanco and R.J. Romañch, "Analysis of low content drug tablets by transmission near infrared spectroscopy: selection of calibration ranges according to multivariate detection and quantitation limits of pis models", J. Pharm. Sci. 97, 5318 (2008). doi: 10.1002/jps.21373
69. C.P. Meza, M.A. Santos and R.J. Romañch, "Quantitation of drug content in a low dosage formulation by transmission near infrared spectroscopy", AAPS PharmSciTech. 7, E1 (2006). doi: 10.1208/pt070129
70. J.L. Ramirez. M.K. Bellamy and R.J. Romañch, "A novel method for analyzing thick tablets by near-infrared spectroscopy", AAPS PharmSciTech. 2, E11 (2001). doi: 10.1208/pt020311
71. Y. Lei, Z-Y. Luo and C.-Q. Hu, "Rapidly screening counterfeit drugs using NIR spectroscopy: combining quantitative analysis with quantitative analysis to increase efficiency". J. Near Infrared Spectrosc. 16, 349 (2008). doi: 10.1255/jnirs.798
72. H.H. Pang, Y.C. Feng, C.Q. Hu and B.R. Xiang, "Construction of universal quantitative models for determination of cefoperazone sodium for injection from different manufacturers using near infrared reflectance spectroscopy", Spectrosc. Spect. Anal. 26, 2214 (2006).
73. W.L. Lo, R.D. Jee and A.C. Moffat. "The identification of counterfeit and sub-standard ibuprofen tablets by near-infrared spectroscopy", J. Pharm. Pharmacol. 59 Supplement 1, A-26 (2007).
74. Y.H.M. Shek. R.D. Jee and A.C. Moffat, "The identification of counterfeit and sub-standard paracetamol tablets by near-infrared spectroscopy", J. Pharm. Pharmacol. 58 Supplement 1, A-3 (2006).
75. R.A. Lodder, M. Selby and G. Hieftje, "Detection of capsule tampering by near-infrared reflectance analysis", Anal. Chem. 59,1921 (1987). doi: 10.1021/ac00142a008
76. J.K. Drennen and R.A. Lodder. "Nondestructive nearinfrared analysis of intact tablets for determination of degradation products", J. Pharm. Sci. 79, 622 (1990). doi: 10.1002/JPS.2600790717
77. R. Mukhopadhyay, "The hunt for counterfeit medicine", Anal. Chem. 79, 2622 (2007). doi: 10.1021/ac071892p
78. A.J. O'Neil, R.D. Jee. G. Lee. A. Charvill and A.C. Moffat, "Use of a portable NIR spectrometer for the authentication of tablets and the detection of counterfeit versions", J. Near Infrared Spectrosc. 16, 327 (2008). doi: 10.1255/ jnirs.796
79. S. Assi, R. Watt and A. Moffat "Detecting counterfeit pharmaceuticals using handheld near-infrared spectroscopy", Polychromix Application Note, http://www.polychromix.com/PDF/counter.pdf (2008).
80. G. Reich, "Near-infrared spectroscopy and imaging: basic principles and pharmaceutical technologies", Adv. Drug. Deliver. Rev. 57, 1109 (2005). doi: 10.1016/j. addr.2005.01.020
81. N.D. Wilson and A.C. Moffat, "The use of near-infrared microscopy for the identification of counterfeit Viagra tablets", J. Pharm. Pharmacol. 56 Supplement, S-3 (2004).
82. M. Veronin and B. Youan, "Near infrared chemical imaging of simvastatin containing tablets obtained through the internet", AAPSJ. 6 Supplement, Abstract 3298 (2004).
83. M.A. Veronin, E. Lee and E.N. Lewis, "Insight into drug quality: comparison of simvastatin tablets from the US and Canada obtained via the internet", Ann. Pharmacother. 41,1111 (2007). doi: 10.1345/aph.1H680
84. M.A. Veronin and B.B Youan, "Medicine Magic bullet gone astray: medications and the internet". Science 305, 481 (2004). doi: 10.1126/science.1097355
85. R. Lyon, C. Ellison, E. Jefferson, E. Lewis, E. Lee, K. Haber and A. Hussain, "Screening pharmaceuticals for authenticity by near-infrared chemical imaging", AAPS J. 6 Supplement, Abstract 2295 (2004).
86. B.J. Westenberger, C.D. Ellison, A.S. Fussner, S. Jenney, R.E. Kolinski. T.G. Lipe. R.C. Lyon, T.W. Moore. L.K. Revelle. A.P Smith, J.A. Spenser, F.D. Storey. D.Y. Toler, A.M. Wokovich and L.F. Buhse, "Quality assessments of internet pharmaceutical products using traditional and non-traditional techniques", Int. J. Pharm. 306, 56 (2005). doi: 10.1016/j.ijpharm.2005.08. 027
87. C. Gendrin, Y. Roggo and C. Collet, "Pharmaceutical applications of vibrational imaging and chemometrics: a review". J. Pharm. Biomed. Anal. 48, 533 (2008). doi: 10.1016/j.jpba.2008.08.014
88. J. Dubois, J.-C Wolf, J.K. Warrack, J. Schoppelrei and E.N. Lewis, "NIR chemical imaging for counterfeit pharmaceutical products analysis", Spectroscopy 22, 40 (2007).
89. M.B. Lopes and J.-C. Wolff, "Investigation into classification/ sourcing of suspect counterfeit Heptodin tablets by near infrared chemical imaging", Anal. Chim. Acta 633, 149 (2009). doi: 10.1016/j.aca.2008.11.036
90. M.B. Lopes. J.-C. Wolff. J.M. Bioucas-Dias and M.AT. Figueiredo, "Determination of the composition of counterfeit Heptodin tablets by near infrared chemical imaging and classical least squares estimation", Anal. Chim. Acta 641, 46 (2009). doi: 10.1016/j.aca.2009.03.034